Published in Parasitol Res on May 01, 2014
Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine. J Med Microbiol (2016) 0.75
Endogenous antimicrobial factors in the treatment of infectious diseases. Cent Eur J Immunol (2017) 0.75
Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A (1987) 8.53
Human cutaneous lieshmania in a mouse macrophage line: propagation and isolation of intracellular parasites. Science (1980) 2.73
In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob Agents Chemother (1999) 2.10
Magainins and the disruption of membrane-linked free-energy transduction. Proc Natl Acad Sci U S A (1989) 1.86
Monoclonal antibody affinity purification of a Leishmania membrane glycoprotein and its inhibition of leishmania-macrophage binding. Proc Natl Acad Sci U S A (1986) 1.65
Targeted gene deletion in Leishmania major identifies leishmanolysin (GP63) as a virulence factor. Mol Biochem Parasitol (2002) 1.65
Molecular determinants of Leishmania virulence. Annu Rev Microbiol (1990) 1.48
The major surface protein of Leishmania promastigotes is a protease. J Biol Chem (1986) 1.33
Leishmaniasis: clinical syndromes and treatment. QJM (2013) 1.27
Extracellular release of the glycosylphosphatidylinositol (GPI)-linked Leishmania surface metalloprotease, gp63, is independent of GPI phospholipolysis: implications for parasite virulence. J Biol Chem (2002) 1.21
Killing of African trypanosomes by antimicrobial peptides. J Infect Dis (2003) 1.21
Targeted gene deletion of Leishmania major genes encoding developmental stage-specific leishmanolysin (GP63). Mol Microbiol (1998) 1.20
The plasma membrane of Leishmania donovani promastigotes is the main target for CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide. Biochem J (1998) 1.14
Migration through the extracellular matrix by the parasitic protozoan Leishmania is enhanced by surface metalloprotease gp63. Infect Immun (2003) 1.13
N-terminal fatty acid substitution increases the leishmanicidal activity of CA(1-7)M(2-9), a cecropin-melittin hybrid peptide. Antimicrob Agents Chemother (2001) 1.11
The major surface-metalloprotease of the parasitic protozoan, Leishmania, protects against antimicrobial peptide-induced apoptotic killing. Mol Microbiol (2006) 1.10
Temporins, small antimicrobial peptides with leishmanicidal activity. J Biol Chem (2004) 1.07
Antimicrobial peptide-induced apoptotic death of leishmania results from calcium-de pend ent, caspase-independent mitochondrial toxicity. J Biol Chem (2009) 1.06
Genetic rescue of surface metalloproteinase (gp63)-deficiency in Leishmania amazonensis variants increases their infection of macrophages at the early phase. Mol Biochem Parasitol (1994) 1.05
Effect of BMAP-28 antimicrobial peptides on Leishmania major promastigote and amastigote growth: role of leishmanolysin in parasite survival. PLoS Negl Trop Dis (2011) 0.95
Interactions of antimicrobial peptides with Leishmania and trypanosomes and their functional role in host parasitism. Exp Parasitol (2010) 0.92
Fibronectin binding and proteolytic degradation by Leishmania and effects on macrophage activation. Infect Immun (2008) 0.92
Improved proteolytic stability of chicken cathelicidin-2 derived peptides by D-amino acid substitutions and cyclization. Peptides (2011) 0.91
Mammalian antimicrobial peptide influences control of cutaneous Leishmania infection. Cell Microbiol (2011) 0.88
Identification of new leishmanicidal peptide lead structures by automated real-time monitoring of changes in intracellular ATP. Biochem J (2003) 0.86
Novel peptide inhibitors of Leishmania gp63 based on the cleavage site of MARCKS (myristoylated alanine-rich C kinase substrate)-related protein. Biochem J (2002) 0.84
Modes of action of Leishmanicidal antimicrobial peptides. Future Microbiol (2012) 0.82
Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity. Acta Trop (2003) 1.20
Infliximab and reactivation of cerebral toxoplasmosis. N Engl J Med (2005) 1.10
The major surface-metalloprotease of the parasitic protozoan, Leishmania, protects against antimicrobial peptide-induced apoptotic killing. Mol Microbiol (2006) 1.10
Rapid screening of antibiotic toxicity in an automated microdroplet system. Lab Chip (2012) 1.09
Antimicrobial peptide-induced apoptotic death of leishmania results from calcium-de pend ent, caspase-independent mitochondrial toxicity. J Biol Chem (2009) 1.06
Evidence for potential functionality of nuclearly-encoded humanin isoforms. Genomics (2009) 1.04
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides. Circulation (2003) 1.02
In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients. Antimicrob Agents Chemother (2005) 1.00
Structure activity relationship studies on the antimicrobial activity of novel edeine A and D analogues. J Pept Sci (2006) 0.96
Molecular determinants and regulation of Leishmania virulence. Kinetoplastid Biol Dis (2002) 0.95
Potential therapeutic role of cationic peptides in three experimental models of septic shock. Antimicrob Agents Chemother (2002) 0.94
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. Antimicrob Agents Chemother (2007) 0.94
Molecular determinants of ciliary membrane localization of Trypanosoma cruzi flagellar calcium-binding protein. J Biol Chem (2011) 0.93
Interactions of antimicrobial peptides with Leishmania and trypanosomes and their functional role in host parasitism. Exp Parasitol (2010) 0.92
Fibronectin binding and proteolytic degradation by Leishmania and effects on macrophage activation. Infect Immun (2008) 0.92
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. J Infect Dis (2005) 0.91
Comparing selection on S. aureus between antimicrobial peptides and common antibiotics. PLoS One (2013) 0.91
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. J Infect Dis (2004) 0.90
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. Peptides (2008) 0.90
The role of Glycyrrhizin, an inhibitor of HMGB1 protein, in anticancer therapy. Arch Immunol Ther Exp (Warsz) (2012) 0.88
Mammalian antimicrobial peptide influences control of cutaneous Leishmania infection. Cell Microbiol (2011) 0.88
Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii. Peptides (2003) 0.86
In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics. Diagn Microbiol Infect Dis (2004) 0.86
Trypanosoma cruzi GP63 proteins undergo stage-specific differential posttranslational modification and are important for host cell infection. Infect Immun (2009) 0.86
Mechanisms of cellular invasion by intracellular parasites. Cell Mol Life Sci (2013) 0.86
Safety profile of antimicrobial peptides: camel, citropin, protegrin, temporin a and lipopeptide on HaCaT keratinocytes. Acta Pol Pharm (2013) 0.85
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. J Antimicrob Chemother (2004) 0.85
Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection. J Vasc Surg (2002) 0.83
Antimicrobial peptides as potential tool to fight bacterial biofilm. Acta Pol Pharm (2014) 0.82
Activity of short lipopeptides and conventional antimicrobials against planktonic cells and biofilms formed by clinical strains of Staphylococcus aureus. Future Med Chem (2012) 0.82
Modes of action of Leishmanicidal antimicrobial peptides. Future Microbiol (2012) 0.82
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. Int J Antimicrob Agents (2005) 0.82
In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci. Antimicrob Agents Chemother (2007) 0.82
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents. Med Mycol (2008) 0.82
Characterization of the effects of opiorphin and sialorphin and their analogs substituted in position 1 with pyroglutamic acid on motility in the mouse ileum. J Pept Sci (2013) 0.82
Activity of Antimicrobial Peptides and Conventional Antibiotics against Superantigen Positive Staphylococcus aureus Isolated from the Patients with Neoplastic and Inflammatory Erythrodermia. Chemother Res Pract (2011) 0.82
In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH(2) alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans. Peptides (2007) 0.81
Voriconazole suppresses the growth of Leishmania species in vitro. Parasitol Res (2013) 0.81
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. Peptides (2005) 0.81
Sorption of ionic liquids onto soils: experimental and chemometric studies. Chemosphere (2012) 0.81
CuII binding sites located at His-96 and His-111 of the human prion protein: thermodynamic and spectroscopic studies on model peptides. Dalton Trans (2008) 0.81
Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study. Pharmacol Res (2013) 0.81
Anticancer effects of CAMEL peptide. Lab Invest (2010) 0.81
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock. J Antimicrob Chemother (2002) 0.80
Antitumor activity of antimicrobial peptides against U937 histiocytic cell line. Acta Biochim Pol (2011) 0.80
In vitro activity and in vivo efficacy of the saponin diosgenyl 2-amino-2-deoxy-β-D-glucopyranoside hydrochloride (HSM1) alone and in combination with daptomycin and vancomycin against Gram-positive cocci. J Med Microbiol (2011) 0.80
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. Peptides (2005) 0.80
In vitro activities of tachyplesin III against Pseudomonas aeruginosa. Peptides (2007) 0.80
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. J Antimicrob Chemother (2005) 0.79
Free fatty acids in the cuticular and internal lipids of Calliphora vomitoria and their antimicrobial activity. J Insect Physiol (2013) 0.79
The -Cys-Cys- motif in Helicobacter pylori's Hpn and HspA proteins is an essential anchoring site for metal ions. Dalton Trans (2011) 0.79
Effect of cryogrinding on chemical stability of the sparingly water-soluble drug furosemide. Pharm Res (2011) 0.79
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. J Antimicrob Chemother (2011) 0.79
Secreted trypanosome cyclophilin inactivates lytic insect defense peptides and induces parasite calcineurin activation and infectivity. J Biol Chem (2013) 0.79
Synthetic amphibian peptides and short amino-acids derivatives against planktonic cells and mature biofilm of Providencia stuartii clinical strains. Pol J Microbiol (2014) 0.78
Amphibian peptides prevent endotoxemia and bacterial translocation in bile duct-ligated rats. Crit Care Med (2006) 0.78
Novel glycosylated endomorphin-2 analog produces potent centrally-mediated antinociception in mice after peripheral administration. Bioorg Med Chem Lett (2013) 0.78
Antimicrobial and conformational studies of the active and inactive analogues of the protegrin-1 peptide. FEBS J (2010) 0.78
In vitro activity and killing effect of uperin 3.6 against gram-positive cocci isolated from immunocompromised patients. Antimicrob Agents Chemother (2005) 0.78
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock. Peptides (2003) 0.77
Structural characterization and antimicrobial activity of the Zn(II) complex with P113 (demegen), a derivative of histatin 5. Inorg Chem (2010) 0.77
Antimicrobial peptides (Temporin A and Iseganan IB-367): effect on the cysticerci of Taenia crassiceps. Mol Biochem Parasitol (2008) 0.77
In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics. J Antimicrob Chemother (2005) 0.76
The His-His sequence of the antimicrobial peptide demegen P-113 makes it very attractive ligand for Cu2+. J Inorg Biochem (2008) 0.76
The antifungal activity of the cuticular and internal fatty acid methyl esters and alcohols in Calliphora vomitoria. Parasitology (2013) 0.76
Activities of synthetic peptides against human pathogenic bacteria. Pol J Microbiol (2004) 0.76
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock. Peptides (2005) 0.76
Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides. J Struct Biol (2009) 0.76
In vitro activity and killing effect of citropin 1.1 against gram-positive pathogens causing skin and soft tissue infections. Antimicrob Agents Chemother (2005) 0.76
Release of biologically active kinin peptides, Met-Lys-bradykinin and Leu-Met-Lys-bradykinin from human kininogens by two major secreted aspartic proteases of Candida parapsilosis. Peptides (2013) 0.76
Composition and antimicrobial activity of fatty acids detected in the hygroscopic secretion collected from the secretory setae of larvae of the biting midge Forcipomyia nigra (Diptera: Ceratopogonidae). J Insect Physiol (2012) 0.76
A novel mechanism of action of the fumagillin analog, TNP-470, in the B16F10 murine melanoma cell line. Anticancer Drugs (2005) 0.76
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. JPEN J Parenter Enteral Nutr (2007) 0.76
The C terminus of HspA--a potential target for native Ni(II) and Bi(III) anti-ulcer drugs. Dalton Trans (2010) 0.76
Cu2+ and Ni2+ interactions with N-terminal fragments of Hpn and Hpn-like proteins from Helicobacter pylori: unusual impact of poly-Gln sequence on the complex stability. J Inorg Biochem (2010) 0.76
Determination of counter-ions in synthetic peptides by ion chromatography, capillary isotachophoresis and capillary electrophoresis. J Pept Sci (2012) 0.76
Competition between histamine-like and poly-imidazole coordination sites for Cu(2+) and Zn(2+) ions in zebra-fish peptide of prion-like protein. Dalton Trans (2010) 0.75
Signal transducer and activator of transcription 1 (STAT-1) plays a critical role in control of Trypanosoma cruzi infection. Immunology (2015) 0.75
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. Antimicrob Agents Chemother (2004) 0.75
Efficacy of the combination of tachyplesin III and clarithromycin in rat models of Escherichia coli sepsis. Antimicrob Agents Chemother (2008) 0.75
In vitro effect of short-term exposure to two synthetic peptides, alone or in combination with clarithromycin or rifabutin, on Cryptosporidium parvum infectivity. Peptides (2002) 0.75
Copper binding to chicken and human prion protein amylodogenic regions: differences and similarities revealed by Ni2+ as a diamagnetic probe. J Inorg Biochem (2009) 0.75
Inactivation of human kininogen-derived antimicrobial peptides by secreted aspartic proteases produced by the pathogenic yeast Candida albicans. Biol Chem (2015) 0.75
Synthesis, biological activity and solution structure of new analogues of the antimicrobial Gramicidin S. J Pept Sci (2010) 0.75
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus. J Med Microbiol (2013) 0.75
Antimicrobial activity of alcohols from Musca domestica. J Exp Biol (2012) 0.75
The coordination abilities of the multiHis-cyclopeptide with two metal-binding centers--potentiometric and spectroscopic investigation. Dalton Trans (2012) 0.75
Biological and surface-active properties of double-chain cationic amino acid-based surfactants. Amino Acids (2014) 0.75
Protective effect of citropin 1.1 and tazobactam-piperacillin against oxidative damage and lethality in mice models of gram-negative sepsis. J Surg Res (2010) 0.75